Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

NCT02526745 is registered in ClinicalTrials.gov with Beijing Chaoyang District Centre for Disease Control and Prevention as lead sponsor.

NCT NCT02526745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older
Lead sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2015
Completion date
Not reported
Enrollment
440 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster